🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementNausea incidence by dose tier — STEP and SURMOUNT meta-analysis Page 2

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis

Dr.Martinez Fri, Mar 13, 2026 at 2:56 AM 16 replies 432 viewsPage 2 of 4
GraceAZ_72
Member
156
678
Jan 2025
Tucson, AZ
Mar 13, 2026 at 5:46 AM#6

The early improvement Michelle describes is consistent with the hypothesis that some of tirz's OSA benefit is weight-independent. Fat deposition in the parapharyngeal space (around the throat) may redistribute or reduce earlier than total body weight change would predict, possibly due to GIP-mediated effects on visceral/ectopic fat deposits.

There's also emerging data on GLP-1 receptor expression in the brainstem respiratory centers (nucleus tractus solitarius) that could influence respiratory drive during sleep. This is very preliminary but mechanistically plausible.

33 17MariaRD, AussieAnna, BethLabQueen and 30 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Mar 13, 2026 at 6:03 AM#7

Thank you all. I'm on 7.5mg currently, 3 months in, down 28 lbs. My wife says the snoring is "significantly better" but not gone. I've got a repeat sleep study scheduled for month 6. Fingers crossed my numbers look like Michelle's. 🤞

Dr. Martinez — thank you for the responsible reminder about not stopping CPAP without proper testing. As much as I hate the machine, I'll wait for data before making any changes.

12 years of CPAP, maybe not 13

Last edited: Mar 13, 2026 at 10:03 AM
22 1ricardo_MIA, BrianDallas92, labquiet_amy and 19 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Mar 13, 2026 at 6:20 AM#8

Brian — 28 lbs in 3 months with subjective snoring improvement is very encouraging. I'd expect your AHI to have improved meaningfully already. The month 6 study will give you the data you need.

And yes — patience with the CPAP. I know it's annoying but unmonitored discontinuation can be dangerous, especially if there's residual moderate-severe OSA. The repeat study will tell you if it's safe to stop.

I'm genuinely excited about where this field is going. The combination of effective weight loss medications and improved PAP technology means we have more tools than ever for OSA management. Good times for our patients. 👍

8 16Dr.NateNeph, PharmD_Rodriguez, julia.endo and 5 others
Reply Quote Save Share Report

Janoshik Analytical — Independent Testing

Trusted third-party HPLC & mass spectrometry analysis. Verify peptide purity with the lab the community relies on. Independent. Accurate. Transparent.

Verify Your Peptides

Similar Threads

Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
Fatigue on semaglutide — caloric deficit vs direct drug effect25 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register